Ten randomized controlled trials were examined to determine the efficacy and safety of glyburide vs insulin treatment for gestational diabetes.
Hyperandrogenic PCOS is associated with maternal pregnancy complications, including gestational diabetes.
Special considerations are needed when treating women of reproductive age with pregestational diabetes.
Researchers examined the relationship between maternal diabetes and asthma risk in children.
Neonates did not differ in terms of birthweight, fat mass, body fat percentage, and sum of skinfolds, regardless of treatment.
One biomarker measurement during pregnancy can identify glucose intolerance with high sensitivity and specificity.
Women who required insulin for gestational diabetes had an increased risk of developing postpartum diabetes.
Gestational diabetes had a 23.3% incidence rate in the combination inositol group compared with 18.3% in the control group.
Pregnant women who took lactobacillus rhamnosus HN001 in their second trimester had lower rates of gestational diabetes.
No difference in incidence of gestational diabetes was noted between those who took inositol supplements vs those who did not.
For patients with gestational diabetes, glyburide and metformin are comparable in terms of glucose control and safety.
Women who were pregnant and slept for less than 6 hours per night or had poor sleep quality had a greater risk of developing gestational diabetes.
The risk of cardiovascular outcomes is elevated for women with gestational diabetes, even in the absence of subsequent type 2 diabetes.
Higher iron stores in the body may increase risk for gestational diabetes.
Early second trimester lipids can identify maternal gestational diabetes, according to a study published in Diabetes Care.
For women with a history of gestational diabetes, having more health visits in the previous year is associated with receiving diabetes screening.
Although a supervised exercise program was not beneficial for reducing recurrence of gestational diabetes, the program improves maternal fitness and is linked to reduction in psychological distress.
Gestational diabetes diagnoses may be more common in the summer than winter.
Babies born to mothers with gestational or pregestational diabetes were more likely to have fetal malformations and other adverse outcomes.
Children born to mothers with gestational diabetes are more likely to be obese at ages 9 to 11.
Obese pregnant women can reduce their risk of gestational diabetes and lower their blood pressure by exercising as little as 3 times a week.
Metabolomics with baseline fasting plasma could predict transition from gestational diabetes to type 2 diabetes.
A tailored mailed letter from pregnant women's health systems improved gestational weight gain.
However, women with insulin secretion defects had similar outcomes as women with normal glucose tolerance.
Elevated blood glucose and excess weight during pregnancy may change the baby's metabolism.
At 1- and 2-hour diagnostic levels, prevalence is lower in winter and higher in summer
Body fat in these infants was 16% higher at 2 months.
A randomized trial shows sizable reduction in fasting plasma glucose, serum insulin levels, and HOMA-IR.
Women with gestational diabetes who adhered to a healthy diet had a 20% lower chance of developing hypertension.
Women who take folic acid supplements during the first trimester of pregnancy may be more likely to develop gestational diabetes.
Endocrinology Advisor Articles
- Imaging Studies in Hypothyroidism Evaluation Linked to Unnecessary Risks
- Transoral Endoscopic Thyroidectomy Vestibular Approach: Safety and Outcomes
- Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
- Insulin Glargine Associated With Breast Cancer Risk in T2D
- High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- Bariatric Surgery: An Effective Treatment for Type 2 Diabetes
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- Increased Risk of Diabetes, Post-Diabetes Pneumonia for Patients With COPD
- Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D
- T2D in African American Women Ups ER-negative Breast Cancer Risk
- High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
- Risks Associated With Denosumab Discontinuation